Skip to main content
. 2021 Feb 13;30(6):1653–1664. doi: 10.1007/s11136-021-02771-y

Table 4.

Difference in EQ-5D scores by sample characteristics (n = 602)

Characteristics EQ-5D-3L 95% CI P-value EQ-VAS 95% CI P-value
Mean ± SD Mean ± SD
Genderb  < 0.001  < 0.001
 Male 0.41  ±  0.44 0.37–0.45 68.90  ±  16.78 67.24–70.57
 Female 0.29  ±  0.32 0.25–0.35 58.73  ±  15.99 56.43–61.02
 Trans gender 0.81  ±  0.03 0.80–0.83 83.50  ±  4.89 81.20–85.79
Ageb  < 0.001  < 0.001
 18–25 years 0.63  ±  0.32 0.58–0.68 78.40  ±  14.38 76.13–80.67
 26–50 years 0.52  ±  0.33 0.48–0.56 67.61  ±  17.11 65.46–69.75
  > 50 years 0.03  ±  0.32 −0.01–0.07 54.74  ±  11.06 53.19–56.29
Marital statusb  < 0.001  < 0.001
 Single 0.57  ±  0.39 0.52–0.62 75.06  ±  14.81 73.19–76.93
 Married/relationship 0.39  ±  0.35 0.33–0.44 64.30  ±  17.71 61.52–67.08
 Divorced/separated 0.20  ±  0.38 0.14–0.26 59.14  ±  15.49 56.74–61.53
 Widowed 0.19  ±  0.39 0.09–0.30 55.74  ±  14.74 51.71–59.76
Level of educationb  < 0.001  < 0.001
 Illiterate 0.29  ±  0.51 0.21–0.36 62.25  ±  16.91 59.71–64.79
 Primary 0.36  ±  0.33 0.32–0.40 61.89  ±  15.49 59.86–63.92
 Secondary 0.39  ±  0.32 0.34–0.44 69.14  ±  13.44 67.07–71.22
 Tertiary 0.48  ±  0.29 0.41–0.55 97.15  ±  4.59 95.59–98.61
Employment statusa  < 0.001  < 0.001
 Employed 0.55  ±  0.37 0.49–0.59 72.34  ±  16.69 70.06–74.62
 Non-employed 0.30  ±  0.41 0.26–0.34 62.92  ±  16.62 61.27–64.57
Since HIV diagnosed (years)b  < 0.001  < 0.001
  < 1 0.57  ±  0.39 0.52–0.62 74.47  ±  15.99 72.12–76.82
 1–5 0.39  ±  0.35 0.33–0.43 62.91  ±  15.90 60.87–69.94
 6–10 0.20  ±  0.38 0.14–0.26 58.25  ±  13.69 55.77–60.72
  > 10 0.19  ±  0.39 0.08–0.31 69.84  ±  20.62 64.68–75.00
HIV serostatusb  < 0.001  < 0.001
 Asymptomatic 0.58  ±  0.37 0.53–0.62 74.75  ±  15.27 72.99–76.52
 Symptomatic 0.26  ±  0.34 0.22–0.29 59.15  ±  15.02 57.41–60.87
 AIDS converted −0.38  ±  0.22 −0.48–0.28 45.10  ±  5.12 42.59–47.40
CD4 countb  < 0.001  < 0.001
  < 200 0.03  ±  0.30 −0.09–0.07 52.21  ±  9.83 50.80–53.61
 200–500 0.34  ±  0.26 0.31–0.37 62.13  ±  12.06 60.58–63.69
  > 500 0.83  ±  0.22 0.79–0.87 86.46  ±  8.25 85.23–87.68
Viral loada  < 0.001  < 0.001
 Detectable 0.22  ±  0.34 0.18–0.26 58.07  ±  12.77 56.60–59.54
 Non-detectable 0.55  ±  0.41 0.50–0.59 73.79  ±  17.40 71.85–75.73
Time on ARTb  < 0.001  < 0.001
  < 12 months 0.50  ±  0.35 0.45–0.55 72.97  ±  14.15 71.11–74.83
 12–48 months 0.56  ±  0.32 0.51–0.62 66.64  ±  18.09 63.61–69.66
  > 48 months 0.18  ±  0.41 0.13–0.23 59.49  ±  16.84 57.33–61.64
How you get infected with HIV?b  < 0.001  < 0.001
 No idea 0.12  ±  0.17 0.09–0.17 55.35  ±  16.49 51.15–59.55
 Blood products 0.30  ±  0.46 0.21–0.39 69.01  ±  14.63 66.35–71.64
 Injecting drugs 0.40  ±  0.41 0.3–0.44 66.45  ±  16.42 64.81–68.09
 Sex with women 0.34  ±  0.31 0.26–0.43 57.40  ±  14.11 53.38–61.41
 Sex with men 0.69  ±  0.32 0.58–0.81 68.18  ±  32.15 56.77–79.58

Bold values show a statistically significant difference

EQ EuroQoL, SD Standard deviation, CI Confidence interval

aIndependent samples t-test

bOne-Way ANOVA was applied to calculate p-value